Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy

Judith Manley; Pamela Maxwell; Daniel Longley; David Waugh; Melissa LaBonte Wilson

Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy

Judith Manley, Pamela Maxwell, Daniel Longley, David Waugh, Melissa LaBonte Wilson

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 2017
Event	European Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” - Belfast, United Kingdom Duration: 25 Nov 2017 → 29 Nov 2017

Conference

Conference	European Alliance for Personalised Medicine Conference
Country/Territory	United Kingdom
City	Belfast
Period	25/11/2017 → 29/11/2017

Keywords

Prostate Cancer
Epigenetic
Entinostat

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Integration of class 1 HDAC inhibitors into current treatments for prostate cancer
Author: Manley, J., Dec 2020
Supervisor: LaBonte Wilson, M. (Supervisor) & Waugh, D. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

@conference{35c1fbafbd71423198c75eda0c9c51ee,

title = "Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy",

keywords = "Prostate Cancer, Epigenetic, Entinostat",

author = "Judith Manley and Pamela Maxwell and Daniel Longley and David Waugh and {LaBonte Wilson}, Melissa",

year = "2017",

language = "English",

note = "European Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” ; Conference date: 25-11-2017 Through 29-11-2017",

}

Expanding the potential for epigenetic targeting therapies in prostate cancer : HDAC inhibition sensitises to radiotherapy. / Manley, Judith; Maxwell, Pamela ; Longley, Daniel; Waugh, David; LaBonte Wilson, Melissa.

2017. Poster session presented at European Alliance for Personalised Medicine Conference , Belfast, United Kingdom.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Expanding the potential for epigenetic targeting therapies in prostate cancer

T2 - European Alliance for Personalised Medicine Conference

AU - Manley, Judith

AU - Maxwell, Pamela

AU - Longley, Daniel

AU - Waugh, David

AU - LaBonte Wilson, Melissa

PY - 2017

Y1 - 2017

KW - Prostate Cancer

KW - Epigenetic

KW - Entinostat

M3 - Poster

Y2 - 25 November 2017 through 29 November 2017

ER -

Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy

Conference

Keywords

UN SDGs

Student Theses

Integration of class 1 HDAC inhibitors into current treatments for prostate cancer

Cite this